Home Cart 0 Sign in  
X

[ CAS No. 2632-10-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 2632-10-2
Chemical Structure| 2632-10-2
Chemical Structure| 2632-10-2
Structure of 2632-10-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2632-10-2 ]

Related Doc. of [ 2632-10-2 ]

Alternatived Products of [ 2632-10-2 ]

Product Details of [ 2632-10-2 ]

CAS No. :2632-10-2 MDL No. :MFCD00051581
Formula : C8H5BrCl2O Boiling Point : -
Linear Structure Formula :- InChI Key :PAKFHEFMTRCFAU-UHFFFAOYSA-N
M.W : 267.93 Pubchem ID :244751
Synonyms :

Calculated chemistry of [ 2632-10-2 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 54.53
TPSA : 17.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.19 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.1
Log Po/w (XLOGP3) : 3.87
Log Po/w (WLOGP) : 3.57
Log Po/w (MLOGP) : 3.37
Log Po/w (SILICOS-IT) : 3.98
Consensus Log Po/w : 3.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.18
Solubility : 0.0178 mg/ml ; 0.0000665 mol/l
Class : Moderately soluble
Log S (Ali) : -3.93
Solubility : 0.0318 mg/ml ; 0.000119 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.84
Solubility : 0.00391 mg/ml ; 0.0000146 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.73

Safety of [ 2632-10-2 ]

Signal Word:Danger Class:8
Precautionary Statements:P280-P301+P330+P331-P280-P305+P351+P338-P310-P302+P352-P301+P312-P304+P340 UN#:3261
Hazard Statements:H314-H302+H312+H332 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 2632-10-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2632-10-2 ]
  • Downstream synthetic route of [ 2632-10-2 ]

[ 2632-10-2 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 2642-63-9 ]
  • [ 2632-10-2 ]
YieldReaction ConditionsOperation in experiment
95% With N-Bromosuccinimide; toluene-4-sulfonic acid In acetonitrile at 80℃; for 5 h; To a solution of compound ii-c-2 (18.8 g, 0.1 mol, 1.0 eq.) in acetonitrile (100 ml) was added p-toluenesulfonic acid (25.8 g, 0.15 mol, 1.5 eq.)And N-bromosuccinimide (17.7 g, 0.1 mol, 1.0 eq.),The reaction solution was refluxed at 80 ° C for 5 h.The organic phase was extracted and concentrated, and the title compound ii-2 (yield 95percent) was obtained by silica gel column chromatography.
157 g at 17 - 20℃; for 0.5 h; To a stirred solution of 3,4-dichloroacetophenone, 135 g (0.714 mol) in acetic acid (675 mL) cooled to 17 °C was added bromine, 37.0 mL (0.722 mol) in acetic acid (360 mL) dropwise. After approximately a third of the bromine had been added no reaction had occurred therefore the reaction mixture was warmed to 25 °C at which point an exotherm to 35 °C occurred. The remainder of the bromine was added and the reaction mixture stirred at room temperature for 30 minutes. The mixture was poured into ice water (1.5 L) while stirring vigorously. The precipitate was collected by filtration and the two batches combined and washed with water. The solid was triturated in diethyl ether (300 mL) to give the desired product 2-bromo-l-(3,4-dichlorophenyl)ethanone, 230 g. The filtrate was washed with brine, dried over magnesium sulfate and concentrated to give a brown oil. The oil was poured into ice/water (1 L) and stirred. The precipitate was collected by filtration to give a second batch of the desired product, 157 g, which were used directly without further purification. ‘HNMR (400 MHz, DMSO-d6): δ [ppm] = 4.95 (s, 2H), 7.81 (d, 1H), 7.91 (dd, 1H), 8.18 (d, 1H). LC (method 1): Rt 2.82 min
Reference: [1] Russian Journal of Organic Chemistry, 1994, vol. 30, # 6.1, p. 881 - 887[2] Zhurnal Organicheskoi Khimii, 1994, vol. 30, # 6, p. 827 - 832
[3] Patent: CN107266388, 2017, A, . Location in patent: Paragraph 0098; 0099; 0100
[4] ChemMedChem, 2018, vol. 13, # 11, p. 1102 - 1114
[5] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 21, p. 7146 - 7153
[6] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2009, vol. 48, # 10, p. 1424 - 1430
[7] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 7, p. 686 - 691
[8] Roczniki Chemii, 1933, vol. 13, p. 293,295[9] Chem. Zentralbl., 1933, vol. 104, # II, p. 1516
[10] Chemische Berichte, 1936, vol. 69, p. 921,924
[11] Journal of the Chemical Society, 1951, p. 255
[12] Journal of medicinal chemistry, 1972, vol. 15, # 9, p. 989 - 994
[13] Chemical and Pharmaceutical Bulletin, 1992, vol. 40, # 5, p. 1170 - 1176
[14] Journal of Medicinal Chemistry, 1998, vol. 41, # 26, p. 5150 - 5157
[15] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 17, p. 2421 - 2423
[16] Journal of agricultural and food chemistry, 2002, vol. 50, # 12, p. 3486 - 3490
[17] Journal of the American Chemical Society, 2004, vol. 126, # 6, p. 1634 - 1635
[18] Synthetic Communications, 2007, vol. 37, # 2, p. 199 - 207
[19] Patent: US5212197, 1993, A,
[20] Patent: US4185105, 1980, A,
[21] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 17, p. 6374 - 6379
[22] Chemistry and Biodiversity, 2010, vol. 7, # 7, p. 1717 - 1727
[23] Letters in Drug Design and Discovery, 2011, vol. 8, # 9, p. 758 - 762
[24] Letters in Drug Design and Discovery, 2011, vol. 8, # 9, p. 758 - 762
[25] European Journal of Medicinal Chemistry, 2012, vol. 52, p. 70 - 81
[26] Tetrahedron, 2013, vol. 69, # 31, p. 6392 - 6398
[27] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 24, p. 6764 - 6768
[28] RSC Advances, 2014, vol. 4, # 5, p. 2177 - 2194
[29] ChemMedChem, 2014, vol. 9, # 1, p. 177 - 188
[30] Advanced Synthesis and Catalysis, 2013, vol. 355, # 18, p. 3570 - 3574
[31] Chemical Communications, 2014, vol. 50, # 51, p. 6726 - 6728
[32] Drug Design, Development and Therapy, 2016, vol. 10, p. 1807 - 1815
[33] Phosphorus, Sulfur and Silicon and the Related Elements, 2016, vol. 191, # 8, p. 1166 - 1173
[34] Patent: WO2016/91845, 2016, A1, . Location in patent: Page/Page column 55
[35] Organic and Biomolecular Chemistry, 2016, vol. 14, # 34, p. 8026 - 8029
[36] Patent: CN105315279, 2016, A, . Location in patent: Paragraph 0136
[37] Patent: CN105669586, 2016, A, . Location in patent: Paragraph 0050
[38] Patent: WO2016/166186, 2016, A1, . Location in patent: Page/Page column 47
[39] Patent: WO2016/166185, 2016, A1, . Location in patent: Page/Page column 36; 37
[40] Letters in Organic Chemistry, 2016, vol. 13, # 9, p. 672 - 677
[41] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 2, p. 1506 - 1513
[42] Phosphorus, Sulfur and Silicon and the Related Elements, 2017, vol. 192, # 4, p. 469 - 474
[43] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 16, p. 3726 - 3732
[44] Journal of the Chinese Chemical Society, 2017, vol. 64, # 12, p. 1408 - 1416
[45] ChemMedChem, 2018, vol. 13, # 1, p. 37 - 47
[46] Chemical Communications (Cambridge, United Kingdom), 2018, vol. 54, # 86, p. 12182 - 12185
  • 2
  • [ 17356-08-0 ]
  • [ 2642-63-9 ]
  • [ 2632-10-2 ]
Reference: [1] Drug Design, Development and Therapy, 2016, vol. 10, p. 1807 - 1815
  • 3
  • [ 95-50-1 ]
  • [ 2632-10-2 ]
Reference: [1] Journal of the Chemical Society, 1951, p. 255
  • 4
  • [ 2632-10-2 ]
  • [ 17356-08-0 ]
  • [ 39893-80-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 22, p. 9031 - 9044
[2] Phosphorus, Sulfur and Silicon and the Related Elements, 2010, vol. 185, # 1, p. 103 - 109
[3] European Journal of Medicinal Chemistry, 2012, vol. 52, p. 70 - 81
[4] Journal of the Chinese Chemical Society, 2017, vol. 64, # 12, p. 1408 - 1416
  • 5
  • [ 2632-10-2 ]
  • [ 39893-80-6 ]
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 39, p. 5265 - 5269
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2632-10-2 ]

Aryls

Chemical Structure| 41011-01-2

[ 41011-01-2 ]

2-Bromo-1-(3-chlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 53631-13-3

[ 53631-13-3 ]

2-Bromo-1-(3,5-dichlorophenyl)ethanone

Similarity: 0.96

Chemical Structure| 536-38-9

[ 536-38-9 ]

2-Bromo-4′-chloroacetophenone

Similarity: 0.96

Chemical Structure| 1011-26-3

[ 1011-26-3 ]

2-Bromo-1-(4-chlorophenyl)butan-1-one

Similarity: 0.88

Chemical Structure| 2631-72-3

[ 2631-72-3 ]

2-Bromo-1-(2,4-dichlorophenyl)ethanone

Similarity: 0.85

Bromides

Chemical Structure| 41011-01-2

[ 41011-01-2 ]

2-Bromo-1-(3-chlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 53631-13-3

[ 53631-13-3 ]

2-Bromo-1-(3,5-dichlorophenyl)ethanone

Similarity: 0.96

Chemical Structure| 536-38-9

[ 536-38-9 ]

2-Bromo-4′-chloroacetophenone

Similarity: 0.96

Chemical Structure| 1011-26-3

[ 1011-26-3 ]

2-Bromo-1-(4-chlorophenyl)butan-1-one

Similarity: 0.88

Chemical Structure| 2631-72-3

[ 2631-72-3 ]

2-Bromo-1-(2,4-dichlorophenyl)ethanone

Similarity: 0.85

Chlorides

Chemical Structure| 41011-01-2

[ 41011-01-2 ]

2-Bromo-1-(3-chlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 53631-13-3

[ 53631-13-3 ]

2-Bromo-1-(3,5-dichlorophenyl)ethanone

Similarity: 0.96

Chemical Structure| 536-38-9

[ 536-38-9 ]

2-Bromo-4′-chloroacetophenone

Similarity: 0.96

Chemical Structure| 1011-26-3

[ 1011-26-3 ]

2-Bromo-1-(4-chlorophenyl)butan-1-one

Similarity: 0.88

Chemical Structure| 2631-72-3

[ 2631-72-3 ]

2-Bromo-1-(2,4-dichlorophenyl)ethanone

Similarity: 0.85

Ketones

Chemical Structure| 41011-01-2

[ 41011-01-2 ]

2-Bromo-1-(3-chlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 53631-13-3

[ 53631-13-3 ]

2-Bromo-1-(3,5-dichlorophenyl)ethanone

Similarity: 0.96

Chemical Structure| 536-38-9

[ 536-38-9 ]

2-Bromo-4′-chloroacetophenone

Similarity: 0.96

Chemical Structure| 1011-26-3

[ 1011-26-3 ]

2-Bromo-1-(4-chlorophenyl)butan-1-one

Similarity: 0.88

Chemical Structure| 2631-72-3

[ 2631-72-3 ]

2-Bromo-1-(2,4-dichlorophenyl)ethanone

Similarity: 0.85